Patent Assignment
Reel/Frame 069516/0338
Security Interest
Recorded: 2024-12-05
Pages: 15
Assignors
SYROS PHARMACEUTICALS, INC.
Executed: 2024-12-04
TYME TECHNOLOGIES, INC.
Executed: 2024-12-04
TYME INC.
Executed: 2024-12-04
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
115 SOUTH UNION ST, SUITE 300, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(55)
Pharmaceutical Compositions and Methods
High-Speed Centrifugal Mixing Devices and Methods of Use
Tyrosine Derivatives and Compositions Comprising Them
Pharmaceutical Compositions and Methods
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Pharmaceutical Compositions and Methods
Pharmaceutical Compositions and Methods
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Pharmaceutical Compositions and Methods
Tyrosine Derivatives and Compositions Comprising Them
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Compounds for the Modulation of Myc Activity
Compounds for the Modulation of Myc Activity
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Pharmaceutical Compositions And Methods
High-Speed Centrifugal Mixing Devices and Methods of Use
Compounds for the Modulation of Myc Activity
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Heteroaromatic Compounds Useful for the Treatment of Proliferative Diseases
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Pharmaceutical Compositions and Methods
High Surface-Area Lyophilized Compositions Comprising Arsenic for Oral Administration in Patients
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Compositions of Cyclin Dependent Kinase 7 (CDK7) Inhibitor
Pharmaceutical Compositions and Methods
Pyrrolotriazine Compounds and Methods of Inhibiting Tam Kinases
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Pharmaceutical Compositions And Methods
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Compositions and Methods for Treating Cancer
Methods of Treating Sars-Cov-2 Infections
Patent:
10,905,698 →
Application:
16/921,071 →
Inhibitors of Cyclin Dependent Kinase 7 (CDK7)
Inhibitors of Cyclin Dependent Kinase 7 (CDK7)
Methods of Treating Sars-Cov-2 Infections
Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Compounds for the Modulation of Myc Activity
Inhibitors of Cyclin Dependent Kinase 7 (CDK7)
Application:
17/687,259 →
Publication:
US 2022/0305014
Methods of Treating Cancer in Biomarker-Identified Patients with Inhibitors of Cyclin-Dependent Kinase 7 (CDK7)
Application:
17/772,747 →
Publication:
US 2023/0000870
Compositions and Methods for Treating Sickle Cell Disease
Application:
17/774,779 →
Publication:
US 2022/0401489
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Application:
17/871,584 →
Publication:
US 2023/0042181
Methods of Treating Cancer in Patients with an Anomalous Kras Gene or Deletions Within Chromosome 9
Application:
17/928,529 →
Publication:
US 2023/0210852
Therapies for Treating Aml and Uses of Rara Agonists, Hypomethylating Agents, and Bcl-2 Inhibitors
Application:
18/019,981 →
Publication:
US 2023/0285339
Lyophilized compositions comprising arsenic
Dosing Regimens for Cyclin-Dependent Kinase 7 (CDK7) Inhibitors
Application:
18/249,209 →
Publication:
US 2024/0034742
Treatment Regimens with Fixed Doses of Tamibarotene
Application:
18/260,537 →
Publication:
US 2024/0091183
Methods of Stratifying Patients for Treatment with Retinoic Acid Receptor-Alpha Agonists
Application:
18/336,658 →
Publication:
US 2024/0102106
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
Application:
18/408,664 →
Publication:
US 2024/0269076
Inhibitors of Cyclin Dependent Kinase 7 (CDK7)
Application:
18/635,402 →
Publication:
US 2024/0360165
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 9, 2014
From: HOFFMAN, STEVEN
To: TYME, INC.
Reel/Frame 033272/0279 →
Assignment of Assignor's Interest
Jul 10, 2014
From: HOFFMAN, STEVEN
To: TYME, INC.
Reel/Frame 033287/0730 →
Assignment of Assignor's Interest
Jul 10, 2014
From: HOFFMAN, STEVEN
To: TYME, INC.
Reel/Frame 033288/0097 →
Security Interest
Jul 16, 2014
From: TYME, INC.
To: CRONE KLINE RINDE LLP
Reel/Frame 033340/0386 →
Security Interest
Jul 16, 2014
From: TYME, INC.
To: CRONE KLINE RINDE LLP
Reel/Frame 033340/0630 →
Security Interest
Jul 16, 2014
From: TYME, INC.
To: CRONE KLINE RINDE LLP
Reel/Frame 033339/0973 →
Release of Security Interest
Jul 26, 2016
From: CKR LAW, LLP F/K/A CRONE KLINE RINDE LLP
To: TYME, INC.
Reel/Frame 039259/0800 →
Release of Security Interest
Oct 27, 2016
From: CKR LAW, LLP F/K/A CRONE KLINE RINDE LLP
To: TYME, INC.
Reel/Frame 040152/0267 →
Release of Security Interest
Oct 27, 2016
From: CKR LAW, LLP F/K/A CRONE KLINE RINDE LLP
To: TYME, INC.
Reel/Frame 040151/0947 →
Release of Security Interest
Oct 27, 2016
From: CKR LAW, LLP F/K/A CRONE KLINE RINDE LLP
To: TYME, INC.
Reel/Frame 040152/0780 →
Assignment of Assignor's Interest
Mar 6, 2017
From: CHEN, MEI WEI; COLLINS, CINDY; EATON, MATTHEW LUCAS; GUENTHER, MATTHEW G.
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 041478/0950 →
Assignment of Assignor's Interest
Jul 19, 2017
From: MCKEOWN, MICHAEL ROBERT; FIORE, CHRISTOPHER; EATON, MATTHEW LUCAS; LEE, EMILY PAYTON
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 043041/0495 →
Assignment of Assignor's Interest
Sep 20, 2017
From: VADDI, KRISHNA; KURUMADDALI, KUMAR
To: ORSENIX HOLDINGS BV
Reel/Frame 043636/0641 →
Assignment of Assignor's Interest
Feb 27, 2018
From: SPROTT, KEVIN; MARINEAU, JASON J.; SCHMIDT, DARBY; BRADLEY, MICHAEL
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 045053/0222 →
Assignment of Assignor's Interest
Apr 4, 2018
From: CIBLAT, STEPHANE; SIDDIQUI, M. ARSHAD; KABRO, ANZHELIKA; LEBLANC, MELISSA
To: PARAZA PHARMA, INC.
Reel/Frame 045433/0788 →
Assignment of Assignor's Interest
Apr 4, 2018
From: PARAZA PHARMA, INC.
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 045433/0952 →
Assignment of Assignor's Interest
May 1, 2018
From: MARINEAU, JASON J.; RAHL, PETER B.; SPROTT, KEVIN; CIBLAT, STEPHANE
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 045684/0910 →
Assignment of Assignor's Interest
May 3, 2018
From: HOFFMAN, STEVEN
To: TYME, INC.
Reel/Frame 046062/0013 →
Assignment of Assignor's Interest
Nov 2, 2018
From: CIBLAT, STEPHANE; KABRO, ANZHELIKA; LEBLANC, MELISSA; LEGER, SERGE
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 047397/0603 →
Assignment of Assignor's Interest
Feb 22, 2019
From: MARINEAU, JASON J.; SPROTT, KEVIN; SCHMIDT, DARBY
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 048406/0052 →
Assignment of Assignor's Interest
Apr 14, 2020
From: PARAZA PHARMA, INC.
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 052391/0563 →
Assignment of Assignor's Interest
Apr 14, 2020
From: CIBLAT, STEPHANE; SOW, BOUBACAR; LAROUCHE-GAUTHIER, ROBIN; BEAUMIER, FRANCIS
To: PARAZA PHARMA, INC.
Reel/Frame 052391/0444 →
Assignment of Assignor's Interest
Apr 14, 2020
From: MARINEAU, JASON J.; RAHL, PETER B.; SPROTT, KEVIN; BERSTLER, LAUREN
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 052391/0246 →
Assignment of Assignor's Interest
May 1, 2020
From: ORSENIX HOLDINGS BV
To: ORSENIX, LLC
Reel/Frame 052544/0327 →
Assignment of Assignor's Interest
Jan 27, 2021
From: ORSENIX, LLC
To: SYROS PHARMACEUTICALS, INC.
Reel/Frame 055044/0652 →